Australia's most trusted
source of pharma news
Monday, 3 August 2026
Monday, 3 August 2026
Subscribe
Login
Eight pharmas win PBS listings
A wave of new treatments has arrived to the PBS with eight companies scoring an August listing, and more than half are for new drugs.
Will this drug finally reach Aust?
Four years on, this company is having another tilt at bringing its long-acting drug to Australia and it's actively pursing public funding
TODAY
GSK, generic makers win TGA nod
New drug considered by the PBAC at its July meeting approved along with two generics of PBS listed medicines
TODAY Approvals Action
Goodbyes: Look who's leaving now
As industry continues to undergo change, so does the Aussie workforce with a number of high-profile exits
31 July
Pharma most-mentioned by AI
Who's named most often in AI generated answers about pharma and when it comes to brand reputation does high-visibility count?
31 July
Pharma the latest Prick on the road
A local pharma was behind a stunt that saw many Sydneysiders bemused when they encountered a particular car driving from the city to the surf
31 July
Aussie boss roasted on LinkedIn
Debate about whether his latest decision was nothing more than a 'giant pain in the ass' for staff or an attempt 'To Do an AZ'
30 July
Latest Jobs
Inside Sales SpecialistInside Sales SpecialistInside Sales SpecialistTerritory ManagerSenior Manager, Market Access ANZTerritory Manager - Capital EquipmentAssociate Director, Market Access & HEOR, CanadaAccount Manager36 more...
Pharma in Focus Jobs
Marketing & Communications (3)
Sales & Customer Relations (18)
- Inside Sales Specialist - Melbourne
- Inside Sales Specialist - Sydney
- Inside Sales Specialist - Brisbane
- Territory Manager - Auckland
- Territory Manager - Capital Equipment - Auckland
- Account Manager - Sydney
- Customer Service Representative - Lane Cove
- Customer Service Manager - Frenchs Forest
- Head of Sales - Community Care - Sydney
- Territory Manager - Devices - Gold Coast
- Business Development Manager - Acute Care - Melbourne
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Sydney
- Territory Manager - Newcastle
- Medical Sales Representative - Sydney
- Logistics and Customer Service Specialist - Belrose
- Customer Service Representative - Keysborough
- Customer Service Administrator - East Ryde
Access & Reimbursement (2)
- Senior Manager, Market Access ANZ - Melbourne
- Associate Director, Market Access & HEOR, Canada - Toronto
Clinical & Medical, R&D (9)
- Clinical Compliance Specialist - 0.6FTE+ - Melbourne / Sydney (remote with some on-site client work)
- Clinical Research Investigator - Allambie Heights
- Clinical Research Associate - Sydney
- Medical Science Liaison - Sydney
- Clinical Research Associate II - Melbourne
- Clinical Trial Study Start Up Specialist - Melbourne
- Medical Sales Representative - Sydney
- Clinical Trial Investigator - Sutherland
- Senior Medical Receptionist - 2IC - Western Australia
Regulatory, Pharmacovigilance & QA (3)
- Senior Technical & Regulatory Associate - Sydney
- Quality Associate - Sydney
- Senior Quality Engineer - Tullamarine
Devices (1)
Executive Roles (2)
- Senior Manager, Market Access ANZ - Melbourne
- Associate Director, Market Access & HEOR, Canada - Toronto
Other (11)
- Senior Project Manager - Operations - Sydney
- Procurement Specialist - North Sydney
- Warehouse Assistant & Forklift Driver - Lane Cove West
- Supply Chain Coordinator - Sydney
- Head of Unlicensed Medicines - Sydney
- BD Lead APAC - Australia, Melbourne Preferred (Remote – Flexible)
- Warehouse Assistant - North Ryde
- Senior Payroll Specialist - Macquarie Park
- Distribution Clerk - Warehousing - Jacana
- Commercial Specialist - Brisbane
- Logistics Planner - North Ryde
Where will this exec land next?
ICYMI: Where is he going? J&J leader hush-hush on next move plus the other most popular stories this week
31 July
Drug short opens new care play
Supply problems seen as an opportunity to educate patients about new care guidelines introduced last year
31 July
Inside PBAC's special meeting
The committee will meet today to discuss a matter that cannot reasonably be deferred to the next scheduled meeting
30 July
Pharmas earning the most bucks
Fortune Magazine has published its list of the top 500 earning companies, and a baker's dozen of pharmas made the grade
30 July
Lilly, Roche sign Alzheimer's plan
Rather than wait for HTA processes, the two pharmas have teamed with NeuRA to pilot a new model of care in detecting and treating Alzheimer's
30 July
Rebel weighs in on GLP1s
Aussie movie star who shed 36kgs backs new wellness campaign that advocates the new trend of 'microdosing' of weight loss meds
29 July
CSL's next-gen tech ready for trials
The Aussie giant is looking for evidence to support the regulatory approval of a more efficient manufacturing process
30 July
Pharma unveils $3.6B restructure
Global CEO declined to provide details on the number of jobs to go following an enterprise-wide review of the company's cost base
29 July
13 times a Great Place to Work
This pharma has once again been certified as a Great Place to Work, marking 13 consecutive years of certification
29 July
Physicians unite to modernise HTA
Two-day Summit will gather Australia's leading cancer specialists, policymakers, patient advocates and industry partners
29 July
MSAC ends four-plus year wait
A radio-based skin cancer treatment, first considered by MSAC's subcommittee in 2021 has finally been given the nod
29 July
Top PBS drugs change hands
Medicines earning hundreds of millions of dollars in reimbursements have new sponsors after changes this month
28 July
Aussie blight on booming drug
Dispute over the costing model means Australians lack PBS access to a drug that is seeing booming take-up around the globe
28 July
Company in strife with UK watchdog
Very serious code breaches after this pharma used "thoroughly misleading data" to disparage a rival's product with more sanctions on the cards
28 July